Dr. Bill Bithoney will review the tectonic shifts in reimbursement for Behavioral Healthcare under the Affordable Care Act. He will also discuss the clinical requirements which insurers and CMS are putting in place in order for BH organizations to receive reimbursement for the care they provide. In the future, insurers will only pay for care which is “evidence based.” Of interest and import is that there is a strong movement afoot to pay for proven telemedicine-based care as well as computerized interventions based in cognitive behavioral therapy. Dr. Bithoney will also discuss the movement to so-called “Value Based Care” wherein patient outcomes and measured quality metrics will have a major impact on provider payment and overall income.
In this webinar, Dr. Bithoney will also review the recent increase in merger and acquisition activity in the field.
- Understand regulatory changes affecting reimbursement for substance abuse and behavioral health programs
- Review the latest medical research on substance abuse and process disorder treatment
- Review the current market environment for mergers and acquisitions in the BH field given changing reimbursement models and value-based purchasing